IFP Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $789K | Buy |
8,264
+5,956
| +258% | +$572K | 0.01% | 846 |
|
|
2026
Q1 | $239K | Sell |
2,308
-3,317
| -59% | -$376K | 0.01% | 1293 |
|
|
2025
Q4 | $567K | Buy |
5,625
+56
| +1% | +$6.08K | 0.01% | 874 |
|
|
2025
Q3 | $687K | Buy |
5,569
+280
| +5% | +$34.8K | 0.02% | 748 |
|
|
2025
Q2 | $635K | Buy |
5,289
+428
| +9% | +$57.1K | 0.02% | 739 |
|
|
2025
Q1 | $716K | Buy |
4,861
+345
| +8% | +$52.7K | 0.02% | 646 |
|
|
2024
Q4 | $733K | Buy |
4,516
+653
| +17% | +$107K | 0.02% | 610 |
|
|
2024
Q3 | $629K | Buy |
3,863
+2,237
| +138% | +$331K | 0.02% | 609 |
|
|
2024
Q2 | $222K | Buy |
1,626
+205
| +14% | +$28.5K | 0.01% | 997 |
|
|
2024
Q1 | $218K | Buy |
1,421
+190
| +15% | +$28.4K | 0.01% | 958 |
|
|
2023
Q4 | $175K | Sell |
1,231
-724
| -37% | -$96.5K | 0.01% | 1007 |
|
|
2023
Q3 | $256K | Buy |
1,955
+314
| +19% | +$47.7K | 0.01% | 852 |
|
|
2023
Q2 | $261K | Buy |
1,641
+12
| +0.7% | +$1.94K | 0.01% | 894 |
|
|
2023
Q1 | $117K | Sell |
1,629
-1,087
| -40% | -$163K | 0.01% | 1175 |
|
|
2022
Q4 | $215K | Sell |
2,716
-1,758
| -39% | -$250K | 0.01% | 1316 |
|
|
2022
Q3 | $343K | Buy |
4,474
+328
| +8% | +$47.3K | 0.01% | 1119 |
|
|
2022
Q2 | $313K | Hold |
4,146
| – | – | 0.01% | 1046 |
|
|
2022
Q1 | $313K | Buy |
4,146
+1,583
| +62% | +$243K | 0.01% | 1046 |
|
|
2021
Q4 | $448K | Sell |
2,563
-96
| -4% | -$16K | 0.01% | 638 |
|
|
2021
Q3 | $442K | Buy |
2,659
+1,088
| +69% | +$187K | 0.01% | 626 |
|
|
2021
Q2 | $283K | Sell |
1,571
-327
| -17% | -$59.7K | 0.01% | 745 |
|
|
2021
Q1 | $369K | Buy |
1,898
+164
| +9% | +$31.6K | 0.01% | 613 |
|
|
2020
Q4 | $349K | Sell |
1,734
-710
| -29% | -$147K | 0.01% | 609 |
|
|
2020
Q3 | $516K | Buy |
2,444
+262
| +12% | +$58.3K | 0.03% | 423 |
|
|
2020
Q2 | $475K | Buy |
2,182
+247
| +13% | +$49.3K | 0.04% | 429 |
|
|
2020
Q1 | $337K | Buy |
1,935
+2
| +0.1% | +$330 | 0.03% | 428 |
|
|
2019
Q4 | $292K | Sell |
1,933
-208
| -10% | -$31.1K | 0.02% | 562 |
|
|
2019
Q3 | $325K | Buy |
+2,141
| New | +$338K | 0.02% | 606 |
|
|
2019
Q1 | $244K | Sell |
1,516
-7,143
| -82% | -$1.11M | 0.03% | 422 |
|
|
2018
Q4 | $1.33M | Sell |
8,659
-2,370
| -21% | -$369K | 0.08% | 273 |
|
|
2018
Q3 | $1.66M | Sell |
11,029
-1,467
| -12% | -$208K | 0.07% | 302 |
|
|
2018
Q2 | $1.69M | Buy |
12,496
+1,070
| +9% | +$132K | 0.07% | 283 |
|
|
2018
Q1 | $1.7M | Hold |
11,426
| – | – | 0.08% | 267 |
|
|
2017
Q4 | $1.7M | Sell |
11,426
-7,061
| -38% | -$961K | 0.08% | 266 |
|
|
2017
Q3 | $2.44M | Sell |
18,487
-312
| -2% | -$41.9K | 0.1% | 228 |
|
|
2017
Q2 | $2.5M | Buy |
18,799
+53
| +0.3% | +$7.15K | 0.11% | 216 |
|
|
2017
Q1 | $2.53M | Sell |
18,746
-772
| -4% | -$100K | 0.11% | 204 |
|
|
2016
Q4 | $2.34M | Buy |
19,518
+8,554
| +78% | +$1.01M | 0.11% | 199 |
|
|
2016
Q3 | $1.37M | Sell |
10,964
-474
| -4% | -$62.1K | 0.07% | 287 |
|
|
2016
Q2 | $1.58M | Buy |
11,438
+9,922
| +654% | +$1.29M | 0.09% | 253 |
|
|
2016
Q1 | $244K | Sell |
1,516
-9,309
| -86% | -$1.18M | 0.03% | 422 |
|
|
2015
Q4 | $1.37M | Buy |
+10,825
| New | +$1.34M | 0.09% | 237 |
|
Other funds holding CLX
IFP Advisors's CLX Position: Q2 2026 in Review
IFP Advisors increased its Clorox (CLX) stake by 258% in Q2 2026, buying an estimated $572K and bringing the position to 8,264 shares worth $789K. The position accounts for 0.01% of the portfolio, ranked #846.
IFP Advisors first reported a position in CLX in Q4 2015 and has held it in 42 quarters since. The position peaked at $2.53M in Q1 2017. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- IFP Advisors held 8,264 shares of Clorox worth $789K as of Q2 2026.
- IFP Advisors bought 5,956 Clorox shares in Q2 2026, an estimated $572K.
- Clorox made up 0.01% of IFP Advisors's portfolio in Q2 2026, its #846 holding.
- IFP Advisors first reported a position in Clorox in Q4 2015 and has held it in 42 quarters since.
- IFP Advisors's Clorox position peaked at $2.53M in Q1 2017.
- 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.